This multi-dimensional approach provides a more comprehensive view of ITGAV’s functional roles in cancer, particularly in relation to the tumor immune microenvironment, and supports its reevaluation as a biomarker and potential therapeutic target in precision oncology. The gene discussed is ITGAV; the disease is cancer.